昆药集团(600422.SH)：前三季度净利润2.69亿元，同比下降39.42%

Core Points - The company reported a revenue of 1.4 billion yuan for Q3 2025, representing a year-on-year decline of 30.19% [1] - The net profit attributable to shareholders was 71.01 million yuan, down 59.03% year-on-year [1] - Basic earnings per share stood at 0.09 yuan for Q3 2025 [1] Financial Performance - For the first three quarters of 2025, the company achieved a total revenue of 4.751 billion yuan, reflecting an 18.08% year-on-year decrease [1] - The net profit attributable to shareholders for the first three quarters was 269 million yuan, a decline of 39.42% compared to the previous year [1] - Basic earnings per share for the first three quarters were reported at 0.36 yuan [1]